社论：动脉僵硬度、中心血液动力学与非酒精性脂肪性肝病：与心血管风险的关联及药物治疗的效果。
Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment.
机构信息
Second Department of Propaedeutic Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.
First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
出版信息
Curr Vasc Pharmacol. 2018;16(4):401-404. doi: 10.2174/1570161116666171205105402.
Arterial stiffness, central haemodynamics and Non-Alcoholic Fatty Liver Disease (NAFLD) have been associated with increased risk for Cardiovascular (CV) morbidity and mortality. Antihypertensive, antidiabetic and hypolipidaemic drugs may affect these predictors of CV risk. Such associations should be taken into consideration when treating high-risk patients.
动脉僵硬、中心血流动力学和非酒精性脂肪性肝病 (NAFLD) 与心血管 (CV) 发病率和死亡率的风险增加有关。抗高血压、抗糖尿病和降血脂药物可能会影响这些 CV 风险预测因素。在治疗高危患者时应考虑到这些关联。
Zotero 插件